藤原 稚也

Medicine & Life Sciences

1. Heart Failure 100%
2. Brain Natriuretic Peptide 71%
3. Acute Kidney Injury 66%
4. Angiotensin Receptor Antagonists 57%
5. Elderly 53%
6. azilsartan 47%
7. Left Atrial Function 37%
8. Takotsubo Cardiomyopathy 35%
9. Rosuvastatin Calcium 34%
10. Fatty Acid-Binding Proteins 33%
11. Hydrochlorothiazide 32%
12. Rhabdomyolysis 32%
13. Early Ambulation 32%
14. Sarcopenia 32%
15. Myocardial Perfusion Imaging 31%
16. fibrin fragment D 30%
17. Hypertrophic Cardiomyopathy 29%
18. Sarcoidosis 28%
19. Area Under Curve 27%
20. Computed Tomography Angiography 26%
21. Chronic Renal Insufficiency 26%
22. Percutaneous Coronary Intervention 25%
23. Blood Pressure 25%
24. Prescriptions 25%
25. Proteinuria 24%
26. Anticoagulants 23%
27. Antihypertensive Agents 23%
28. Bone Density 23%
29. Atrial Fibrillation 22%
30. Myocardial Ischemia 22%
31. Salts 22%
32. Walking 22%
33. Biomarkers 21%
34. MicroRNAs 21%
35. Intensive Care Units 21%
36. Coronary Vessels 21%
37. Registries 20%
38. Walking Speed 19%
39. Creatinine 19%
40. Fatty Liver 19%
41. Hypertension 19%
42. Lipids 18%
43. Tomography 17%
44. Pressure 16%
45. Hydroxymethylglutaryl-CoA Reductase Inhibitors 16%
46. Serum 16%
47. Glucose 16%
48. Safety 15%
49. Renin 14%
50. Electrocardiography 13%